To: scaram(o)uche who wrote (103 ) 3/26/1999 8:29:00 AM From: Mike McFarland Respond to of 52153
Amerindo's wizards --No, I've only been getting into biotech for about the past year...what is the Amerindo story all about? Braveheart et al--I am not as optimistic for the sector as I was before H&Q...seems like the market is very slowly rolling over and getting ready to sink. Instead of the internut enthusiasm rotating into a new sector, it just seems to be fading. You mentioned that you thought you would pick up some more biotech this summer. I think I learned my lesson last year, and I will only do a little shopping, and not til next fall. And apparently the best time to shop is during the after-Christmas sales at tax loss selling finishes. Oh, we could still see our sector wake up this year, would not take much to turn sentiment around. Imagine if a few of the munch predictions came through--wham! A lot of money would suddenly find it's way over to biotech, and then there is BIO '99, that could help get some of these story stocks into the papers as well. I'm just not quite yet ready to send a check off to a taxable account and load up on on of my gene therapy stocks, and double it on margin;-) In fact, I still havn't switched my ira to a Roth, so any further damage to the sector is a tax advantage for me... Should have converted last fall at the October bottom --geeze, my main acct was down to 30k and I could have spread that tax out over four years...sigh. Then things bounced back and I watched my tax liability double by H&Q. I may never convert. I just hate cutting checks for the IRS--and I suppose that is most of the reason I'm not trading stocks in my taxable account anymore. Still, there will be a point when these biotechs will be so alarmingly cheap that I'll have to throw some taxable money at them...